Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 138 entries
View as:

A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])

Phase: N/A Priority: Normal
NCT ID: NCT05615363 Org: User:
Start: 01/10/23 End: 10/21/24 Due: 10/21/25

Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake

Phase: N/A Priority: Normal
NCT ID: NCT03962101 Org: User:
Start: 06/17/19 End: 06/30/20 Due: 06/30/21

A Phase 2 Trial of OPC-64005 for Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04244253 Org: User:
Start: 03/03/20 End: 02/25/22 Due: 02/25/23

A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT05119894 Org: User:
Start: 11/22/21 End: 12/06/21 Due: 12/06/22

Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)

Phase: N/A Priority: Normal
NCT ID: NCT00234065 Org: User:
Start: 12/31/03 End: 12/31/08 Due: 12/31/09

A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02679469 Org: User:
Start: 02/29/16 End: 03/31/16 Due: 03/31/17

A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02220712 Org: User:
Start: 07/31/14 End: 04/30/15 Due: 04/30/16

A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)

Phase: N/A Priority: Normal
NCT ID: NCT02069119 Org: User:
Start: 02/28/14 End: 08/31/15 Due: 08/31/16

Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male Adults

Phase: N/A Priority: Normal
NCT ID: NCT03342963 Org: User:
Start: 11/21/17 End: 01/18/18 Due: 01/18/19

A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]

Phase: N/A Priority: Normal
NCT ID: NCT00841568 Org: User:
Start: 04/30/06 End: 11/30/10 Due: 11/30/11

A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00666965 Org: User:
Start: 06/30/08 End: 08/31/09 Due: 08/31/10

Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT03303092 Org: User:
Start: 12/19/17 End: 11/22/19 Due: 11/22/20

A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan]

Phase: N/A Priority: Normal
NCT ID: NCT01280721 Org: User:
Start: 11/30/10 End: 08/31/14 Due: 08/31/15

Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02108288 Org: User:
Start: 04/30/14 End: 08/31/14 Due: 08/31/15

A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)

Phase: N/A Priority: Normal
NCT ID: NCT00544869 Org: User:
Start: 10/31/07 End: 02/28/09 Due: 02/28/10

A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT01628965 Org: User:
Start: 01/31/08 End: 10/31/10 Due: 10/31/11

A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration

Phase: N/A Priority: Normal
NCT ID: NCT01876381 Org: User:
Start: 06/30/13 End: 02/28/14 Due: 02/28/15

Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)

Phase: N/A Priority: Normal
NCT ID: NCT01084551 Org: User:
Start: 02/28/10 End: 09/30/11 Due: 09/30/12

Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg

Phase: N/A Priority: Normal
NCT ID: NCT03902574 Org: User:
Start: 03/27/19 End: 06/18/19 Due: 06/18/20

Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02293993 Org: User:
Start: 01/07/15 End: 05/31/19 Due: 05/31/20

Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT00233389 Org: User:
Start: 04/30/04 End: 09/09/05 Due: 09/09/06

A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients

Phase: N/A Priority: Normal
NCT ID: NCT03284177 Org: User:
Start: 10/31/17 End: 12/04/18 Due: 12/04/19

Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT03724942 Org: User:
Start: 11/09/18 End: 01/05/22 Due: 01/05/23

Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00504426 Org: User:
Start: 07/31/07 End: 05/31/09 Due: 05/31/10

A Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy Subject

Phase: N/A Priority: Normal
NCT ID: NCT01737931 Org: User:
Start: 08/31/12 End: 11/30/12 Due: 11/30/13